No phaseStatus unknownAge-related condition
Anthocyanins as Dementia Prevention? (ACID)
A Randomized, 24-week Parallel-group Placebo-controlled Multicenter (Phase 2) Study of Anthocyanins in People at Risk for Dementia
- Sponsor
- Helse Stavanger HF (Government)
- Enrollment
- 212 enrolled
- Conditions
- Dementia; Inflammation; Mild Cognitive Impairment; Coronary Artery Disease
- Interventions
- Anthocyanins; Placebo
- Ages
- adults, older adults
- Registry
- NCT03419039
Full record on ClinicalTrials.gov
From the registry
The aim of this project is to study the safety and efficacy of anthocyanins in improving key dementia-related mechanisms and cognitive functioning in older people at risk for dementia. Secondary analyses will include a variety of biological measures, including biochemistry, imaging and cardiovascular measures.
Primary outcomes
- Quality of episodic memory.
History
Primary completion
Last registry update
Registered
Started
Papers citing this trial
- Effects of Oral Anthocyanin Supplementation on In Vitro Neurogenesis, Hippocampus-Dependent Cognition, and Blood-Based Dementia Biomarkers: Results from a 24-Week Randomized Controlled Trial in Older Adults At Risk for Dementia (ACID)
Nutrients
- Anthocyanin supplementation in adults at risk for dementia: a randomized controlled trial on its cardiometabolic and anti-inflammatory biomarker effects
GeroScience
- A Randomised Placebo-Controlled Study of Purified Anthocyanins on Cognition in Individuals at Increased Risk for Dementia
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
- Effects of Purified Anthocyanins in People at Risk for Dementia: Study Protocol for a Phase II Randomized Controlled Trial
Frontiers in neurology